1 National Tuberculosis Programme. 2 53 million 676,577 sq km (75/sq km) A major public health problem ARI 1.66% (1972), 1.5% (1994) 162/100,000 est.

Slides:



Advertisements
Similar presentations
UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
Advertisements

Karin Weyer WHO Stop TB Department Stop TB Partnership Global Laboratory Initiative.
Planning in line with the Stop TB Strategy and the Global Plan to Stop TB, Dr Win Maung Programme Manager National Tuberculosis Programme Ministry.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Improving diagnosis TB laboratory strengthening.
Overview of strategy for FY 14 Myanmar. CAP-TB: Goal To reduce the incidence and mortality from MDR TB in Myanmar In partnership with National Tuberculosis.
Key elements to develop a national strategic plan for TB control Malgosia Grzemska Stop TB Department WHO, Geneva, Switzerland EURO/TBTEAM Regional Workshop.
Dr. Phyu Phyu Swe Health Services Manager (TB)
Thailand National Focal Point for IFCS Chemical Safety Section Food and Drug Administration Ministry of Public Health July 2003.
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
1 [INSERT COUNTRY NAME HERE] Introduction to the National MDR-TB Control Strategy SESSION 1 Insert country/ministry logo here.
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
Introduction Thailand one of 22 countries which contain 80% of the estimated tuberculosis (TB) cases in the world. Thailand ranks 17 th among the 22 high-burden.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Comprehensive M&E Systems
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Revised National Tuberculosis Control Programme (RNTCP)
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
National TB/ Leprosy Programme Manager
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
TB/HIV/AIDS Prevention and Management in the Workplace: Forging new partnerships- by Thinking Ahead Anthony Pramualratana.
1 TB/HIV Project in the Philippines Yumiko Yanase.
The Value of Partnerships in Fighting HIV/AIDS in Romania: Bringing Children New Hope Jeffrey L. Sturchio Vice President, External Affairs Europe, Middle.
Framework and Standards for Effective TB Control Module 3 – March 2010
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Project Goals  Support the National Tb Program (NTP)  Developed National Guidelines for prevention and control of Tb  Developed guidelines for treating.
U pdates on the development of the NTP National Strategic Plan GC National TB Conference Pokhara, July 14-15, 2014 Giampaolo Mezzabotta Medical.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
Progress and plans for PPM in the WHO Region of the Americas Fifth PPM Subgroup Meeting June, Cairo.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Report of the 2nd ad hoc Committee on the TB epidemic Jaap F. Broekmans STOP TB Partner’s Forum NEW DELHI June 2004.
National Tuberculosis Control Program in Bangladesh : Progress Report Dr. Shamim Sultana Deputy Programme Manager, TB National TB Control Programme.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
TB infection control and prevention of XDR Group II.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
Gap Analysis: Tuberculosis Care in Malawi Round 11 proposal to the Global Fund to Fight AIDS, Tuberculosis and Malaria Africa 3: Team Malawi Arianna, Babatunde,
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
TB- HIV Collaborative activities in Romania- may 2006 status
Increased access to quality TB drugs
Strengthening EMIS Capacity towards EFA Monitoring in Myanmar
TB/HIV surveillance : Who is going to get the job done?
Knowledge gaps in formulating TB Control Policies for Prisons
Key issues in DOTS implementation
TB Strategy & Health Systems (TBS) TB Monitoring & Evaluation (TME)
Vietnam Investment and Finance for TB
Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility
From TB control to integrated respiratory disease control
5th DEWG meeting Conclusions
Dr. Kenneth L. Chebet Director NASCOP/NLTP Division Kenya
South Africa: From ProTest to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Fabio Scano IUATLD Conference Paris, 2003
Presentation transcript:

1 National Tuberculosis Programme

2 53 million 676,577 sq km (75/sq km) A major public health problem ARI 1.66% (1972), 1.5% (1994) 162/100,000 est. incidence (WHO report 2003, Global TB control) About 85,000 new cases of TB per year Half of them being infectious. Estimated 100/100,000 population is all smear positive TB cases (1994) Estimated 75/100,000 population is new smear positive TB cases (1994) HIV sero-prevalence among TB patients – 4.5% ( ) MDR-TB among new sear positive cases 1.25% institutional based ( )

3 O RGANIZATION S ET-UP OF N ATIONAL T UBERCULOSIS P ROGRAMME OF M YANMAR HEALTH MINISTER DEPUTY HEALTH MINISTER DIRECTOR GENERAL DY. DIRECTOR GENERAL (Medical Care) DY. DIRECTOR GENERAL (Public Health/Disease Control) Director (Med. Care) Director (Lab.) Director (Nursing) Director (Planning) Director (Admin) Director (Disease Control) Director (Public Health) Director (Food & Drug)0 Deputy Director (TB Control) 3 Assistant Directors (TB Control) S/DTB OS TB OD TB OS TB O D TB OS TB OS/D TB OD TB O S TB O YangonMandalay Kachin Shan(S) Kayah Ayeyar- waddy Mon Kayin BagoRakhineSagaing Chin(N) Tanin- tharyi State / Divisions # DistrictTownshipRHC DTB O Shan(N) Magway Chin (S) DTB O S TB O Shan(E) DTBO = Divisional TB Officer STBO = State TB Officer Director (Occupational Health) No. of districts with TB team = 43 / 63 No. of townships with TB team = 58/324 No. of townships with TB staff = 46 / 324

4 Central Supervisory Committee for Prevention and Control of TB Chairman -Minister for Health Vice Chairman- Deputy Minister for Health Members -Director of Medical Service Ministry of Defense Director Generals from Ministry of Health Directors from Dept. of Health, Dept. of Medical Science, Presidents of Local NGOs, and other officials from National TB Programme 4

5 1966NTP implementation started. 1978NTP was integrated to Basic Health Services under PHC programme 1994NTP introduced 18 SCC Townships. 1997DOTS strategy has been introduced. Oct’ townships DOTS covered (Total coverage) 6 History of National TB Programme Myanmar

6 DOTS COVERED TOWNSHIPS ( )

7

8 DOTS Progress Towards Targets Target

9 Government contribution YearRegular Budget DrugsTotal ,771 14,527 16,017 18,777 20,509 62,747 68,470 74, ,614 5,000 19,600 25,000 30,000 35,000 14,493 16,141 21,017 38,377 45,509 92, , ,349 (Kyats in thousands)

10 Partnerships PartnersContribution WHO:Technical training / local abroad, IEC materials, drugs and lab. supplies UNDPTB drugs for 11 townships (up to 2002) JICA for training and training materials for 48 townships in 3 divisions (Mandalay, Sagaing and Magway divisions) GDFWill support for three years now, receiving Second year support JATA6 townships, for training, UNHCR2 townships in Rakhine State for TB drugs and lab reagents AZG2 townships in Kachin State for drugs and lab. activities IUATLD3 cars and lab. equipment 1. Existing partners and their contribution 2. Collaborative activities with -National AIDS Programme - Private sector (GP) - Other public sector (Ministry of Labour - Social Security Board, Ministry of Industry, Myanmar Railway) and local NGOs (MMCWA, MMA)

11 100% DOTS coverage (324 townships) achieved in 2003 from 259 townships in Additional TB diagnostic and treatment centres were opened in Yangon in 2001 and in Mandalay in More IEC materials and health talks among community and Co- operation with other sectors – NAP/ private public partnership / NGOs / Social Security Board / Ministry of Industry/Myanmar Railways Resource mobilization: situation, allocation, availability at start of proposed activities, GDF supply started form end of 2001 . Capacity building: refresher training, training for new recruit, international training to all health staffs, NGOs, private sector. Progress made in

12 Progress made in contd. Myanmar-Thai border TB/HIV collaboration is strengthened. Treatment guideline for TB/HIV co-infection is developed in Operational research are doing in collaboration with TDR, DMR and NTP in area of drug resistance TB, Fixed Dose Combination Drugs, assessment of community involvement in DOTS implementation. NTP, Myanmar will be supported 17 million for 5 years for GFATM. Vehicles, lab. equipments supported from IUATLD. Strengthening of manpower – 1 created post of Sr. Consultant Microbiologist, 2 created Assistant Directors for central level and 4 State/Divisional TB Officers for state/divisional level. Programme treatment policy changed form fully intermitted regimen to daily regimen using with 4 - Fixed Dose Combination (4FDC)

13 Progress in Laboratory (120) Binocular Microscopes are distributed during the year Received Microscopes and laboratory equipment from (IUATLD) for strengthening of National TB Reference Laboratory and network. Laboratory Quality Control System covered all State/Divisions with concordance over 90%. Lot Quality Assurance System (LQAS) has been introduced at state/divisional level in 2002 onward.

14 Resources required for 1 year Budget HeadPlanned CostAvailableExpected (GFATM) Funding Gap Human Resource 489,867270, Infrastructure/ Equipment 2,367,000-1,971,000396,000 Training / Planning 422, ,50080,000 Commodities / Products 1,140, ,064,66143,340 Drugs 1,033, ,517 Monitoring & Evaluation 201,05077,300121,9001,850 Administrative 215, Other (Research) 331, Total 6,201,5081,055,2934,216,508929,707 Available = Government + WHO +GDF

15  Low community awareness about TB and facilities available for diagnosis and treatment  Lack of transport and insufficient skilled staff at all levels for key activities  Drug supplies are partially secured up to 2010 with the support of GDF and GFATM  Availability of low quality anti-TB drugs leading to Multi-Drug Resistant TB  Data management – delay in flow of data due to manual management.  Co-infection with HIV  Weak co-operation with private sector in case finding and proper referral  Floating population  Different geographic terrain and language barrier Constraints

16 Train programme staffs and improve infrastructure at central and peripheral levels for better programme management and training of laboratory staffs and provide adequate microscopes to ensure an effective and quality assured laboratory network. Develop a strategy for an effective IEC campaign. Establishment of microscopy centre at station health units to achieve the strategy of microscopy centre for 1/50,000 population. Exploring of alternative source of assistance and potential partners for secured drug supplies. Installation of user friendly computerized data management system and facilitated reporting via fax or . Scale up existing collaborative activities: TB-HIV projects etc. and scaling up of existing Public-Private Partnership, and develop a referral system for whole country in Future Plan

17